Nicotine Dependence Clinical Trials
2 recruiting trials for Nicotine Dependence. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Nicotine Dependence clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Massachusetts General Hospital (1), National Institute of Cardiology, Warsaw, Poland (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is QuitVaping (behavioral, 1 trial), followed by This is Quitting (TIQ), heated tobacco - lifestyle intervention.
Track Nicotine Dependence trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Behavioral Intervention for Youth to Promote Vaping Cessation
This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to...
Effects of Switching From Cigarettes to Tobacco Heating System on Coronary Atherosclerosis Progression
Objective: To evaluate the impact of heated versus combustion tobacco products on progression of atherosclerosis in patients with CAD unable(unwilling) to quit smoking....
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Nicotine Dependence, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Nicotine Dependence, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Nicotine Dependence, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.